Emerging treatments in multiple sclerosis

Details

Serval ID
serval:BIB_BDCF0293C1CD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Emerging treatments in multiple sclerosis
Journal
European Neurology
Author(s)
Schluep  M., Bogousslavsky  J.
ISSN
0014-3022 (Print)
Publication state
Published
Issued date
1997
Volume
38
Number
3
Pages
216-21
Notes
Journal Article
Review
Abstract
Currently used and developing therapies for multiple sclerosis (MS) are dealing with the treatment of acute exacerbations, the prevention of relapses and of the progression of neurological handicap, the treatment of symptoms, and the repair of demyelinated lesions. New insights into the treatment of acute relapses as well as recent immunomodulatory and immunosuppressive agents tested in MS are exposed in this brief review. Interferon-beta (1a and 1b), copolymer 1 and new immunosuppressive therapies are particularly discussed with emphasis on their potential to alter the course of MS.
Keywords
Adjuvants, Immunologic/therapeutic use Disease Progression Humans Immunosuppressive Agents/therapeutic use Interferon-beta/therapeutic use Multiple Sclerosis/*therapy Palliative Care/trends Recurrence/prevention & control Steroids/therapeutic use
Pubmed
Web of science
Create date
25/01/2008 12:46
Last modification date
20/08/2019 15:32
Usage data